Picture of Allena Pharmaceuticals logo

ALNAQ — Allena Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Allena Pharmaceuticals Inc - Filed A Voluntary Petition For Relief Under The Provisions Of Chapter 11 Of Title 11 Of The United States Code

Sept 2 (Reuters) - Allena Pharmaceuticals Inc  ALNA.O :
    * ALLENA PHARMACEUTICALS INC - FILED A VOLUNTARY PETITION
FOR
RELIEF UNDER THE PROVISIONS OF CHAPTER 11 OF TITLE 11 OF THE
UNITED STATES CODE
    * ALLENA PHARMACEUTICALS INC - HAS APPOINTED MATTHEW FOSTER
AS THE
COMPANY’S CHIEF RESTRUCTURING OFFICER, EFFECTIVE AS OF SEPTEMBER
2, 2022
    * ALLENA PHARMACEUTICALS-  TERMINATED EMPLOYMENT OF
SUBSTANTIALLY
ALL OF ITS EMPLOYEES, INCLUDING LOUIS BRENNER, PRESIDENT AND CEO
AND RICHARD KATZ, CFO
    * ALLENA PHARMACEUTICALS-  INTENDS TO CONTINUE TO OPERATE
ITS
BUSINESS AT REDUCED LEVEL AS A “DEBTOR-IN-POSSESSION” UNDER THE
JURISDICTION OF COURT

Further company coverage:  ALNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Allena Pharmaceuticals

See all news